Atea Pharmaceuticals
AVIR
Rank
4285
Country
USA
Exchange
NASDAQ
Currency
USD
Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Address
125 SUMMER STREET, 16TH FLOOR, BOSTON, MA, US
Atea Pharmaceuticals - Key figures
Market cap
731.83 Million
Revenue
285.38 Million
Profit
184.16 Million
P/E Ratio
16.28
P/s Ratio
2.564
Atea Pharmaceuticals - Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapies for patients suffering from viral infections.
The company is headquartered in Boston, Massachusetts.